Please enable JavaScript to continue using this application.

Compare $HRGN vs $TIL | Chartloom

Compare

$HRGN vs $TIL

Harvard Apparatus Regenerative Technology Inc · Instil Bio Inc

HRGN

Harvard Apparatus Regenerative Technology Inc

TIL

Instil Bio Inc

Compare $HRGN vs $TIL

Comparing Harvard Apparatus Regenerative Technology Inc and Instil Bio Inc

HRGNHarvard Apparatus Regenerative Technology Inc

TILInstil Bio Inc

HRGNHarvard Apparatus Regenerative Technology Inc

Market cap

$40M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

44.6%

YTD performance

16.2%

52W performance

-15.8%

FCF yield

-9.0%

TILInstil Bio Inc

Market cap

$46M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-40.2%

52W performance

-67.2%

FCF yield

-73.6%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

HRGN

TIL

Detailed metrics comparison

HRGN

Harvard Apparatus Regenerative Technology Inc

TIL

Instil Bio Inc

Market Cap

HRGN$40M

TIL$46M

Enterprise Value

HRGN$41M

TIL$125M

Price

HRGN$2.30

TIL$6.74

P/E Ratio

HRGNN/A

TILN/A

P/S Ratio

HRGN41.18x

TIL0.00x

EV/Sales

HRGN41.33x

TIL0.00x

EV/EBITDA

HRGN0.00x

TIL0.00x

P/B Ratio

HRGN507.11x

TIL0.46x

P/FCF Ratio

HRGNN/A

TILN/A

EV/FCF

HRGN-11.16x

TIL-3.73x

PEG Ratio

HRGNN/A

TILN/A

Forward P/E (NTM)

HRGNN/A

TILN/A

Forward P/S (NTM)

HRGNN/A

TILN/A

Revenue (TTM)

HRGN$982K

TIL$0

Revenue Growth (YoY)

HRGN44.6%

TILN/A

Forward Rev Growth

HRGN0.0%

TIL0.0%

Gross Margin (TTM)

HRGN7.5%

TIL0.0%

Operating Margin (TTM)

HRGN0.0%

TIL0.0%

EBITDA Margin (TTM)

HRGN-682.9%

TIL0.0%

Net Margin (TTM)

HRGN-680.5%

TIL0.0%

FCF Margin (TTM)

HRGN-370.2%

TILN/A

Net Income (TTM)

HRGN$-7M

TIL$-30M

FCF (TTM)

HRGN$-4M

TIL$-34M

EPS (TTM)

HRGN-$0.38

TIL-$4.46

ROE (TTM)

HRGN-78637.0%

TIL-2678.0%

ROA (TTM)

HRGN-30701.0%

TIL-1489.0%

ROIC (TTM)

HRGN-77233.0%

TIL-1529.0%

Cash

HRGN$351K

TIL$6M

Debt

HRGN$500K

TIL$85M

Net Cash/Debt

HRGN$-149K

TIL$-80M

Current Ratio (TTM)

HRGN0.26x

TIL21.67x

Quick Ratio (TTM)

HRGN0.12x

TIL21.19x

Debt/Equity (TTM)

HRGN0.00x

TIL0.79x

Debt/Assets (TTM)

HRGN0.0%

TIL0.0%

Interest Coverage (TTM)

HRGNN/A

TILN/A

Net Debt/EBITDA (TTM)

HRGN0.00x

TIL0.00x

Beta

HRGN-0.50

TIL1.90

52W Performance

HRGN-15.8%

TIL-67.2%

YTD Performance

HRGN16.2%

TIL-40.2%

% from 52W High

HRGN-21.2%

TIL-69.3%

% from 52W Low

HRGN145.8%

TIL18.9%

Asset Turnover (TTM)

HRGN0.45x

TIL0.00x

FCF Yield (TTM)

HRGN-9.0%

TIL-73.6%

Earnings Yield (TTM)

HRGN-16.5%

TIL-66.3%

Dividend Yield (TTM)

HRGNN/A

TILN/A

Rule of 40

HRGN-325.5

TIL0.0

EV/GP/RG

HRGNN/A

TILN/A

Ticker research

View HRGN research View TIL research

Metric	HRGN Harvard Apparatus Regenerative Technology Inc	TIL Instil Bio Inc
Market & Valuation
Market Cap	$40M	$46M
Enterprise Value	$41M	$125M
Price	$2.30	$6.74
P/E Ratio	N/A	N/A
P/S Ratio	41.18x	0.00x
EV/Sales	41.33x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	507.11x	0.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.16x	-3.73x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$982K	$0
Revenue Growth (YoY)	44.6%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	7.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-682.9%	0.0%
Net Margin (TTM)	-680.5%	0.0%
FCF Margin (TTM)	-370.2%	N/A
Net Income (TTM)	$-7M	$-30M
FCF (TTM)	$-4M	$-34M
EPS (TTM)	-$0.38	-$4.46
ROE (TTM)	-78637.0%	-2678.0%
ROA (TTM)	-30701.0%	-1489.0%
ROIC (TTM)	-77233.0%	-1529.0%
Financial Health
Cash	$351K	$6M
Debt	$500K	$85M
Net Cash/Debt	$-149K	$-80M
Current Ratio (TTM)	0.26x	21.67x
Quick Ratio (TTM)	0.12x	21.19x
Debt/Equity (TTM)	0.00x	0.79x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.50	1.90
52W Performance	-15.8%	-67.2%
YTD Performance	16.2%	-40.2%
% from 52W High	-21.2%	-69.3%
% from 52W Low	145.8%	18.9%
Efficiency & Yields
Asset Turnover (TTM)	0.45x	0.00x
FCF Yield (TTM)	-9.0%	-73.6%
Earnings Yield (TTM)	-16.5%	-66.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-325.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View HRGN research	View TIL research

Valuation

P/S Ratio

TIL

0.00x

HRGN

41.18x

EV/FCF

HRGN

-11.16x

TIL

-3.73x

Growth & revenue

Revenue Growth TTM

HRGN

44.6%

Forward Revenue Growth

HRGN

0.0%

TIL

0.0%

Profitability & performance

Gross Margin

HRGN

7.5%

TIL

0.0%

ROE

TIL

-2678.0%

HRGN

-78637.0%

FCF Yield %

HRGN

-9.0%

TIL

-73.6%

52-Week Performance

HRGN

-15.8%

TIL

-67.2%

Detailed metrics comparison

HRGN

Harvard Apparatus Regenerative Technology Inc

TIL

Instil Bio Inc

Market Cap

HRGN$40M

TIL$46M

Enterprise Value

HRGN$41M

TIL$125M

Price

HRGN$2.30

TIL$6.74

P/E Ratio

HRGNN/A

TILN/A

P/S Ratio

HRGN41.18x

TIL0.00x

EV/Sales

HRGN41.33x

TIL0.00x

EV/EBITDA

HRGN0.00x

TIL0.00x

P/B Ratio

HRGN507.11x

TIL0.46x

P/FCF Ratio

HRGNN/A

TILN/A

EV/FCF

HRGN-11.16x

TIL-3.73x

PEG Ratio

HRGNN/A

TILN/A

Forward P/E (NTM)

HRGNN/A

TILN/A

Forward P/S (NTM)

HRGNN/A

TILN/A

Revenue (TTM)

HRGN$982K

TIL$0

Revenue Growth (YoY)

HRGN44.6%

TILN/A

Forward Rev Growth

HRGN0.0%

TIL0.0%

Gross Margin (TTM)

HRGN7.5%

TIL0.0%

Operating Margin (TTM)

HRGN0.0%

TIL0.0%

EBITDA Margin (TTM)

HRGN-682.9%

TIL0.0%

Net Margin (TTM)

HRGN-680.5%

TIL0.0%

FCF Margin (TTM)

HRGN-370.2%

TILN/A

Net Income (TTM)

HRGN$-7M

TIL$-30M

FCF (TTM)

HRGN$-4M

TIL$-34M

EPS (TTM)

HRGN-$0.38

TIL-$4.46

ROE (TTM)

HRGN-78637.0%

TIL-2678.0%

ROA (TTM)

HRGN-30701.0%

TIL-1489.0%

ROIC (TTM)

HRGN-77233.0%

TIL-1529.0%

Cash

HRGN$351K

TIL$6M

Debt

HRGN$500K

TIL$85M

Net Cash/Debt

HRGN$-149K

TIL$-80M

Current Ratio (TTM)

HRGN0.26x

TIL21.67x

Quick Ratio (TTM)

HRGN0.12x

TIL21.19x

Debt/Equity (TTM)

HRGN0.00x

TIL0.79x

Debt/Assets (TTM)

HRGN0.0%

TIL0.0%

Interest Coverage (TTM)

HRGNN/A

TILN/A

Net Debt/EBITDA (TTM)

HRGN0.00x

TIL0.00x

Beta

HRGN-0.50

TIL1.90

52W Performance

HRGN-15.8%

TIL-67.2%

YTD Performance

HRGN16.2%

TIL-40.2%

% from 52W High

HRGN-21.2%

TIL-69.3%

% from 52W Low

HRGN145.8%

TIL18.9%

Asset Turnover (TTM)

HRGN0.45x

TIL0.00x

FCF Yield (TTM)

HRGN-9.0%

TIL-73.6%

Earnings Yield (TTM)

HRGN-16.5%

TIL-66.3%

Dividend Yield (TTM)

HRGNN/A

TILN/A

Rule of 40

HRGN-325.5

TIL0.0

EV/GP/RG

HRGNN/A

TILN/A

Ticker research

View HRGN research View TIL research

Metric	HRGN Harvard Apparatus Regenerative Technology Inc	TIL Instil Bio Inc
Market & Valuation
Market Cap	$40M	$46M
Enterprise Value	$41M	$125M
Price	$2.30	$6.74
P/E Ratio	N/A	N/A
P/S Ratio	41.18x	0.00x
EV/Sales	41.33x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	507.11x	0.46x
P/FCF Ratio	N/A	N/A
EV/FCF	-11.16x	-3.73x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$982K	$0
Revenue Growth (YoY)	44.6%	N/A
Forward Rev Growth	0.0%	0.0%
Profitability
Gross Margin (TTM)	7.5%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-682.9%	0.0%
Net Margin (TTM)	-680.5%	0.0%
FCF Margin (TTM)	-370.2%	N/A
Net Income (TTM)	$-7M	$-30M
FCF (TTM)	$-4M	$-34M
EPS (TTM)	-$0.38	-$4.46
ROE (TTM)	-78637.0%	-2678.0%
ROA (TTM)	-30701.0%	-1489.0%
ROIC (TTM)	-77233.0%	-1529.0%
Financial Health
Cash	$351K	$6M
Debt	$500K	$85M
Net Cash/Debt	$-149K	$-80M
Current Ratio (TTM)	0.26x	21.67x
Quick Ratio (TTM)	0.12x	21.19x
Debt/Equity (TTM)	0.00x	0.79x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	-0.50	1.90
52W Performance	-15.8%	-67.2%
YTD Performance	16.2%	-40.2%
% from 52W High	-21.2%	-69.3%
% from 52W Low	145.8%	18.9%
Efficiency & Yields
Asset Turnover (TTM)	0.45x	0.00x
FCF Yield (TTM)	-9.0%	-73.6%
Earnings Yield (TTM)	-16.5%	-66.3%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-325.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View HRGN research	View TIL research